Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial - van den Eertwegh, A J; Versluis, J; van den Berg, H P (Lancet Oncol, 2012)
et al.